158 related articles for article (PubMed ID: 11741432)
41. Unravelling the conformational plasticity of the extracellular domain of a prokaryotic nAChR homologue in solution by NMR.
Chasapis CT; Argyriou AI; Corringer PJ; Bentrop D; Spyroulias GA
Biochemistry; 2011 Nov; 50(45):9681-3. PubMed ID: 22007668
[TBL] [Abstract][Full Text] [Related]
42. A computational study of the binding of 3-(arylidene) anabaseines to two major brain nicotinic acetylcholine receptors and to the acetylcholine binding protein.
Slavov SH; Radzvilovits M; LeFrancois S; Stoyanova-Slavova IB; Soti F; Kem WR; Katritzky AR
Eur J Med Chem; 2010 Jun; 45(6):2433-46. PubMed ID: 20236734
[TBL] [Abstract][Full Text] [Related]
43. Examination of structural characteristics of the potent oxytocin antagonists [dPen1,Pen6]-OT and [dPen1,Pen6, 5-tBuPro7]-OT by NMR, Raman, CD spectroscopy and molecular modeling.
Bélec L; Blankenship JW; Lubell WD
J Pept Sci; 2005 Jul; 11(7):365-78. PubMed ID: 15641022
[TBL] [Abstract][Full Text] [Related]
44. Design, synthesis, and conformational analysis of eight-membered cyclic peptidomimetics prepared using ring closing metathesis.
Creighton CJ; Leo GC; Du Y; Reitz AB
Bioorg Med Chem; 2004 Aug; 12(16):4375-85. PubMed ID: 15265489
[TBL] [Abstract][Full Text] [Related]
45. alpha-Conotoxin GI benzoylphenylalanine derivatives. (1)H-NMR structures and photoaffinity labeling of the Torpedo californica nicotinic acetylcholine receptor.
Kasheverov IE; Chiara DC; Zhmak MN; Maslennikov IV; Pashkov VS; Arseniev AS; Utkin YN; Cohen JB; Tsetlin VI
FEBS J; 2006 Apr; 273(7):1373-88. PubMed ID: 16689926
[TBL] [Abstract][Full Text] [Related]
46. Targeted molecular dynamics study of C-loop closure and channel gating in nicotinic receptors.
Cheng X; Wang H; Grant B; Sine SM; McCammon JA
PLoS Comput Biol; 2006 Sep; 2(9):e134. PubMed ID: 17009865
[TBL] [Abstract][Full Text] [Related]
47. Assembly of nicotinic and other Cys-loop receptors.
Tsetlin V; Kuzmin D; Kasheverov I
J Neurochem; 2011 Mar; 116(5):734-41. PubMed ID: 21214570
[TBL] [Abstract][Full Text] [Related]
48. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions.
Huang X; Zheng F; Chen X; Crooks PA; Dwoskin LP; Zhan CG
J Med Chem; 2006 Dec; 49(26):7661-74. PubMed ID: 17181149
[TBL] [Abstract][Full Text] [Related]
49. In silico characterization of cytisinoids docked into an acetylcholine binding protein.
Abin-Carriquiry JA; Zunini MP; Cassels BK; Wonnacott S; Dajas F
Bioorg Med Chem Lett; 2010 Jun; 20(12):3683-7. PubMed ID: 20493692
[TBL] [Abstract][Full Text] [Related]
50. The beta-turn scaffold of tripeptide containing an azaphenylalanine residue.
Lee HJ; Park HM; Lee KB
Biophys Chem; 2007 Jan; 125(1):117-26. PubMed ID: 16890344
[TBL] [Abstract][Full Text] [Related]
51. Identification and functional characterization of a novel acetylcholine-binding protein from the marine annelid Capitella teleta.
McCormack T; Petrovich RM; Mercier KA; DeRose EF; Cuneo MJ; Williams J; Johnson KL; Lamb PW; London RE; Yakel JL
Biochemistry; 2010 Mar; 49(10):2279-87. PubMed ID: 20136097
[TBL] [Abstract][Full Text] [Related]
52. Ligand-induced conformational change in the alpha7 nicotinic receptor ligand binding domain.
Henchman RH; Wang HL; Sine SM; Taylor P; McCammon JA
Biophys J; 2005 Apr; 88(4):2564-76. PubMed ID: 15665135
[TBL] [Abstract][Full Text] [Related]
53. Crystal structure of Escherichia coli thioredoxin reductase refined at 2 A resolution. Implications for a large conformational change during catalysis.
Waksman G; Krishna TS; Williams CH; Kuriyan J
J Mol Biol; 1994 Feb; 236(3):800-16. PubMed ID: 8114095
[TBL] [Abstract][Full Text] [Related]
54. Agonist-driven conformational changes in the inner beta-sheet of alpha7 nicotinic receptors.
McLaughlin JT; Fu J; Rosenberg RL
Mol Pharmacol; 2007 May; 71(5):1312-8. PubMed ID: 17325129
[TBL] [Abstract][Full Text] [Related]
55. Acetylcholine-binding proteins: functional and structural homologs of nicotinic acetylcholine receptors.
Smit AB; Celie PH; Kasheverov IE; Mordvintsev DY; van Nierop P; Bertrand D; Tsetlin V; Sixma TK
J Mol Neurosci; 2006; 30(1-2):9-10. PubMed ID: 17192605
[TBL] [Abstract][Full Text] [Related]
56. Engineering cyclic tetrapeptides containing chimeric amino acids as preferred reverse-turn scaffolds.
Che Y; Marshall GR
J Med Chem; 2006 Jan; 49(1):111-24. PubMed ID: 16392797
[TBL] [Abstract][Full Text] [Related]
57. Interactions of acetylcholine binding site residues contributing to nicotinic acetylcholine receptor gating: role of residues Y93, Y190, K145 and D200.
Mallipeddi PL; Pedersen SE; Briggs JM
J Mol Graph Model; 2013 Jul; 44():145-54. PubMed ID: 23831994
[TBL] [Abstract][Full Text] [Related]
58. Characterization and three-dimensional structure determination of psi-conotoxin Piiif, a novel noncompetitive antagonist of nicotinic acetylcholine receptors.
Van Wagoner RM; Jacobsen RB; Olivera BM; Ireland CM
Biochemistry; 2003 Jun; 42(21):6353-62. PubMed ID: 12767216
[TBL] [Abstract][Full Text] [Related]
59. The alphaM1 transmembrane segment of the nicotinic acetylcholine receptor interacts strongly with model membranes.
De Planque MR; Rijkers DT; Liskamp RM; Separovic F
Magn Reson Chem; 2004 Feb; 42(2):148-54. PubMed ID: 14745794
[TBL] [Abstract][Full Text] [Related]
60. Conformers of cysteine and cysteine sulfenic acid and mechanisms of the reaction of cysteine sulfenic acid with 5,5-dimethyl-1,3-cyclohexanedione (dimedone).
Freeman F; Adesina IT; La JL; Lee JY; Poplawski AA
J Phys Chem B; 2013 Dec; 117(50):16000-12. PubMed ID: 24274619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
